Exergaming for Better Physical Fitness

Sedentary Lifestyle Clinical Trial

Official title:

Effects of 8 Weeks of High-intensity Exergaming on Cardiorespiratory Fitness and Physical Activity Levels in Sedentary Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04112329
• Other study ID #: 2019/1083
• Status: Completed
• Phase: N/A
• Start date: October 14, 2019
• Est. completion date: March 1, 2020

Study information

• Verified date: May 2021
• Source: Norwegian University of Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this project is to assess if playing a newly developed videogame that require physical activity (e.g. exergame) can lead to increased physical activity, aerobic fitness and health benefits in sedentary adults. The project will include 28 sedentary adults, 18 years and above, who are not sufficiently active according to current guidelines defined as doing (<150 minutes/week of moderate intensity physical activity or <75 minutes/week of vigorous physical activity and/or do not do any regular endurance training ). The physical fitness (maximal oxygen consumption), blood pressure, body composition and objectively measured physical activity will be tested before and after the intervention period. Also, the participants gaming frequency will be registered throughout the 8 week period. Aim of this study is to investigate if access to this game can provide health benefits for adults who are not motivated to take part in regular physical activity.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 29
• Est. completion date: March 1, 2020
• Est. primary completion date: March 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Sedentary (<150 mins of moderate intensity physical activity/week) and/or do not regularly take part in endurance training.
• Able to ride a bike for up to 60 minutes

Exclusion Criteria:

• Known cardiovascular disease
• Taking beta-blockers or anti-arrhythmic drugs

Related Conditions & MeSH terms

• Sedentary Lifestyle

Intervention

Behavioral:
• Exergaming
will use the PlayPulse exergame for 45 minutes a minimum of two times per week for 8 weeks.

Locations

Country	Name	City	State
Norway	Department of Circulation and Medical Imaging	Trondheim

Sponsors (1)

Lead Sponsor	Collaborator
Norwegian University of Science and Technology

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Berg J, Haugen G, Wang AI, Moholdt T. High-intensity exergaming for improved cardiorespiratory fitness. A randomised, controlled trial. Eur J Sport Sci. 2021 May 4:1-30. doi: 10.1080/17461391.2021.1921852. [Epub ahead of print] — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	VO2max (Maximal Aerobic Capacity)		8 weeks
Secondary	Daily average energy expenditure	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).	8 weeks
Secondary	Daily average number of steps	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).	8 weeks
Secondary	Daily time in sedentary activity (< 3.0 metabolic equivalents = METs)	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).	8 weeks
Secondary	Daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs)	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).	8 weeks
Secondary	Daily time in vigorous intensity activity (6.0-9.0 metabolic equivalents = METs)	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).	8 weeks
Secondary	Daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs)	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).	8 weeks
Secondary	Daily average total physical activity duration	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).	8 weeks
Secondary	Bioelectrical impedance	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (weeks).	8 weeks
Secondary	Blood Pressure		8 weeks